ALNYLAM PHARMACEUTICALS INC (ALNY) Stock Earnings & Estimates
USA - NASDAQ:ALNY - US02043Q1076 - Common Stock
453.56 USD
+1.39 (+0.31%)
453.56 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.037B 22.87% | 1.828B 76.24% | 2.248B 22.97% | 3.57B 58.79% | 4.989B 39.75% | 6.359B 27.46% | 7.916B 24.48% | 9.314B 17.66% | 10.28B 10.37% | 10.688B 3.97% | 11.042B 3.31% | |
| EBITDA YoY % growth | -740.6M -12.03% | -228.121M 69.20% | -120.215M 47.30% | 223.71M 286.09% | 1.098B 390.81% | 1.874B 70.67% | 6.335B 238.05% | 9.235B 45.78% | 10.745B 16.35% | 3.49B -67.52% | 3.927B 12.52% | |
| EBIT YoY % growth | -785.1M -10.78% | -282.175M 64.06% | -176.885M 37.31% | 324.64M 283.53% | 836.79M 157.76% | 1.763B 110.69% | 2.647B 50.14% | 3.563B 34.61% | 4.436B 24.50% | 5.039B 13.59% | 5.731B 13.73% | |
| Operating Margin | -75.68% | -15.43% | -7.87% | 9.09% | 16.77% | 27.72% | 33.44% | 38.25% | 43.15% | 47.15% | 51.90% | |
| EPS YoY % growth | -8.66 -21.63% | -3.56 58.89% | -2.17 39.04% | 0.87 140.18% | 5.26 503.50% | 10.83 105.80% | 20.28 87.27% | 24.43 20.49% | 28.70 17.47% | 28.80 0.33% | 32.31 12.19% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.43 149.43% | 1.63 351.51% | 0.66 249.14% | 0.83 262.13% | 1.25 191.41% | 1.79 9.50% |
| Revenue Q2Q % growth | 964.88M 92.62% | 1.225B 106.52% | 1.102B 85.46% | 1.218B 57.43% | 1.233B 27.79% | 1.378B 12.49% |
| EBITDA Q2Q % growth | 52.367M 252.22% | 344.28M 810.02% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 104.83M 236.31% | 232.96M 321.53% | 115.29M 537.77% | 173M 1,167.97% | 101.8M -2.89% | 183.2M -21.36% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.51 -292.31% | -0.78 | 0.27 | 34.98% |
| Q1 2025 Q2Q % growth | -0.44 15.38% | -1.05 | 0.61 | 58.28% |
| Q4 2024 Q2Q % growth | -0.65 40.91% | -0.64 | -0.01 | -2.21% |
| Q3 2024 Q2Q % growth | -0.87 -175.65% | -0.91 | 0.04 | 4.00% |
| Q2 2024 Q2Q % growth | -0.13 94.12% | -1.10 | 0.97 | 88.19% |
| Q1 2024 Q2Q % growth | -0.52 62.86% | -1.21 | 0.69 | 56.90% |
| Q4 2023 Q2Q % growth | -1.10 34.52% | -1.35 | 0.25 | 18.47% |
| Q3 2023 Q2Q % growth | 1.15 142.75% | -1.36 | 2.51 | 184.40% |
| Q2 2023 Q2Q % growth | -2.21 3.49% | -1.40 | -0.81 | -58.30% |
| Q1 2023 Q2Q % growth | -1.40 30.00% | -1.80 | 0.40 | 22.24% |
| Q4 2022 Q2Q % growth | -1.68 22.22% | -1.91 | 0.23 | 12.09% |
| Q3 2022 Q2Q % growth | -2.69 -64.02% | -1.78 | -0.91 | -51.47% |
| Q2 2022 Q2Q % growth | -2.29 -42.24% | -1.66 | -0.63 | -37.75% |
| Q1 2022 Q2Q % growth | -2.00 -16.96% | -1.88 | -0.12 | -6.57% |
| Q4 2021 Q2Q % growth | -2.16 -3.35% | -1.57 | -0.59 | -37.46% |
| Q3 2021 Q2Q % growth | -1.64 24.77% | -1.60 | -0.04 | -2.56% |
| Q2 2021 Q2Q % growth | -1.61 -3.21% | -1.65 | 0.04 | 2.16% |
| Q1 2021 Q2Q % growth | -1.71 6.56% | -1.76 | 0.05 | 3.03% |
| Q4 2020 Q2Q % growth | -2.09 18.68% | -1.74 | -0.35 | -19.89% |
| Q3 2020 Q2Q % growth | -2.18 -13.54% | -1.67 | -0.51 | -30.49% |
| Q2 2020 Q2Q % growth | -1.56 19.17% | -1.75 | 0.19 | 10.74% |
| Q1 2020 Q2Q % growth | -1.83 -5.78% | -1.92 | 0.09 | 4.60% |
| Q4 2019 Q2Q % growth | -2.57 | -2.25 | -0.32 | -14.15% |
| Q3 2019 Q2Q % growth | -1.92 | -2.08 | 0.16 | 7.55% |
| Q2 2019 Q2Q % growth | -1.93 | -1.88 | -0.05 | -2.54% |
| Q1 2019 Q2Q % growth | -1.73 | -2.11 | 0.38 | 18.04% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 773.689M 17.26% | 669.92M | 103.769M | 15.49% |
| Q1 2025 Q2Q % growth | 594.189M 20.20% | 597.54M | -3.351M | -0.56% |
| Q4 2024 Q2Q % growth | 593.166M 34.90% | 595.47M | -2.304M | -0.39% |
| Q3 2024 Q2Q % growth | 500.919M -33.26% | 543.76M | -42.841M | -7.88% |
| Q2 2024 Q2Q % growth | 659.825M 107.00% | 452.99M | 206.835M | 45.66% |
| Q1 2024 Q2Q % growth | 494.333M 54.82% | 435.88M | 58.453M | 13.41% |
| Q4 2023 Q2Q % growth | 439.718M 31.26% | 451.75M | -12.032M | -2.66% |
| Q3 2023 Q2Q % growth | 750.53M 183.97% | 391.21M | 359.32M | 91.85% |
| Q2 2023 Q2Q % growth | 318.754M 41.79% | 357.52M | -38.766M | -10.84% |
| Q1 2023 Q2Q % growth | 319.29M 49.69% | 318.5M | 790K | 0.25% |
| Q4 2022 Q2Q % growth | 335M 29.59% | 319.4M | 15.6M | 4.88% |
| Q3 2022 Q2Q % growth | 264.3M 40.88% | 297.59M | -33.29M | -11.19% |
| Q2 2022 Q2Q % growth | 224.8M 1.90% | 261M | -36.2M | -13.87% |
| Q1 2022 Q2Q % growth | 213.3M 20.10% | 248.24M | -34.94M | -14.08% |
| Q4 2021 Q2Q % growth | 258.5M 58.01% | 238.3M | 20.2M | 8.48% |
| Q3 2021 Q2Q % growth | 187.6M 49.01% | 223.07M | -35.47M | -15.90% |
| Q2 2021 Q2Q % growth | 220.6M 112.12% | 196.66M | 23.94M | 12.17% |
| Q1 2021 Q2Q % growth | 177.6M 78.49% | 172.11M | 5.49M | 3.19% |
| Q4 2020 Q2Q % growth | 163.6M 128.17% | 149.74M | 13.86M | 9.26% |
| Q3 2020 Q2Q % growth | 125.9M 79.60% | 123.17M | 2.73M | 2.22% |
| Q2 2020 Q2Q % growth | 104M 132.66% | 101.47M | 2.53M | 2.49% |
| Q1 2020 Q2Q % growth | 99.5M 198.80% | 93.552M | 5.948M | 6.36% |
| Q4 2019 Q2Q % growth | 71.7M | 73.026M | -1.326M | -1.82% |
| Q3 2019 Q2Q % growth | 70.1M | 57.539M | 12.561M | 21.83% |
| Q2 2019 Q2Q % growth | 44.7M | 70.584M | -25.884M | -36.67% |
| Q1 2019 Q2Q % growth | 33.3M | 24.065M | 9.235M | 38.38% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 420.17% | 184.16% | 0% | 163.37% |
| Revenue | 1.76% | 30.64% | -0.11% | 21.43% |